nandrolone decanoate has been researched along with Lung Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Israel, HL; Schwartz, ML | 1 |
| Ali, I; Block, JB; Chlebowski, JS; Chlebowski, RT; Heber, D; Herrold, J; Oktay, E; Ponce, AT | 1 |
| Antilli, A; Cruciani, AR; De Luca, S; de Sanctis, C; Gargiulo, P; Mugnaini, L; Signora, M; Succi, A | 1 |
1 trial(s) available for nandrolone decanoate and Lung Neoplasms
| Article | Year |
|---|---|
Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer.
Topics: Anabolic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nandrolone; Nandrolone Decanoate; Random Allocation | 1986 |
2 other study(ies) available for nandrolone decanoate and Lung Neoplasms
| Article | Year |
|---|---|
Severe anemia as a manifestation of metastatic jugular paraganglioma.
Topics: Adult; Anemia; Erythropoietin; Female; Glomus Jugulare Tumor; Humans; Lung Neoplasms; Nandrolone; Nandrolone Decanoate; Paraganglioma, Extra-Adrenal | 1983 |
[Hematological toxicity and nandrolone decanoate during polychemotherapy of bronchogenic carcinoma. Preliminary note].
Topics: Aged; Anabolic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Bone Marrow; Carcinoma, Bronchogenic; Cisplatin; Cyclophosphamide; Humans; Lung Neoplasms; Male; Middle Aged; Nandrolone; Nandrolone Decanoate; Vinblastine | 1986 |